This attack does 30 damage times the amount of Psychic Energy attached to this Pokémon.
Switch all damage counters on this Pokémon with those on your opponent's Active Pokémon.
BREAKthrough entered circulation in 2015. Series classification for this set is XY.
Set size is 165 cards, which categorizes BREAKthrough as mid-size. As of 2026, the set is 11 years old and now falls into an established back-catalog period.
Within this set, Mewtwo-EX is card number 164 with a Rare Secret designation.
Mewtwo-EX is a BREAKthrough card from the 2015 release window. Its card type is Pokémon.
The rarity label is Rare Secret. Printed HP is 170.
Energy typing is Psychic. This print is categorized under the Basic and EX subtype.
Card rules text: Pokémon-EX rule: When a Pokémon-EX has been Knocked Out, your opponent takes 2 Prize cards. Attack line includes "Shatter Shot" and "Damage Change".
Mewtwo-EX (BREAKthrough) is presently valued at about $138.56 in raw condition. Week-over-week change is limited (+0.9%), indicating short-term stability.
That is close to the 30-day average of $136.10. Its 90-day trading band runs between $134.70 and $138.56, producing a 3% range and low-volatility behavior.
This version is categorized as Rare Secret.
A wider Mewtwo-EX checklist helps contextualize this specific Mewtwo-EX print. Comparable entries in this snapshot: 6 cards, 2 distinct sets.
Observed alternatives run from $7.48 to $169.65 (2168% spread). The current card sits +145% versus the sampled alternative average of $56.53.
Notable alternatives include Mewtwo-EX #XY107 (XY Black Star Promos) at $10.92, Mewtwo-EX #XY125 (XY Black Star Promos) at $81.80, Mewtwo-EX #XY183 (XY Black Star Promos) at $14.15, and Mewtwo-EX #61 (BREAKthrough) at $7.48.
Pricing context for collectors: Over the last 7 days, prices have remained stable at +0.9%, indicating a consolidation phase over sudden breakouts. With a 3% 90-day spread ($134.70-$138.56), this card currently tracks as low-volatility.
Relative to the 30-day baseline ($136.10), pricing is near equilibrium. Graded context points to a substantial premium curve, with PSA 10 at +2033% above raw pricing.
PSA 9 is currently around $361.89, while PSA 10 is $2955.59.
